StockData
Addex Therapeutics Ltd. logo

Addex Therapeutics Ltd. (ADXN) stock

ADXNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on May 15, 2026Score 0/30
$3.50−0.33 (-8.62%)

Close on Nov 17, 2026Market cap $71.86KP/E –Yield –

Addex Therapeutics ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

No ebitda figures for Addex Therapeutics

Addex Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Addex Therapeutics figures

See a number that looks wrong?